Literature DB >> 25647431

PharmGKB summary: very important pharmacogene information for human leukocyte antigen B.

Julia M Barbarino1, Deanna L Kroetz, Teri E Klein, Russ B Altman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25647431      PMCID： PMC4356642          DOI： 10.1097/FPC.0000000000000118

Source DB:  PubMed          Journal:  Pharmacogenet Genomics        ISSN： 1744-6872            Impact factor:   2.089


× No keyword cloud information.
  152 in total

1.  The HCP5 single-nucleotide polymorphism: a simple screening tool for prediction of hypersensitivity reaction to abacavir.

Authors:  Sara Colombo; Andri Rauch; Margalida Rotger; Jacques Fellay; Raquel Martinez; Christoph Fux; Christine Thurnheer; Huldrych F Günthard; David B Goldstein; Hansjakob Furrer; Amalio Telenti
Journal:  J Infect Dis       Date:  2008-09-15       Impact factor: 5.226

2.  External quality assessment of HLA-B*5701 reporting: an international multicentre survey.

Authors:  Emma Hammond; Coral-Ann Almeida; Cyril Mamotte; David Nolan; Elizabeth Phillips; Tineke Asma Schollaardt; M John Gill; Jonathan B Angel; Doris Neurath; Jianping Li; Tony Giulivi; Cathy McIntyre; Galina Koultchitski; Betty Wong; Marciano Reis; Anita Rachlis; David E Cole; Choo Beng Chew; Stefan Neifer; Richard Lalonde; Michel Roger; Annie Jeanneau; Simon Mallal
Journal:  Antivir Ther       Date:  2007

Review 3.  Fever, rash, and systemic symptoms: understanding the role of virus and HLA in severe cutaneous drug allergy.

Authors:  Rebecca Pavlos; Simon Mallal; David Ostrov; Yuri Pompeu; Elizabeth Phillips
Journal:  J Allergy Clin Immunol Pract       Date:  2014 Jan-Feb

Review 4.  HLA alleles and hypersensitivity to carbamazepine: an updated systematic review with meta-analysis.

Authors:  Sandeep Grover; Ritushree Kukreti
Journal:  Pharmacogenet Genomics       Date:  2014-02       Impact factor: 2.089

5.  Genetic variations in HLA-B region and hypersensitivity reactions to abacavir.

Authors:  Seth Hetherington; Arlene R Hughes; Michael Mosteller; Denise Shortino; Katherine L Baker; William Spreen; Eric Lai; Kirstie Davies; Abigail Handley; David J Dow; Mary E Fling; Michael Stocum; Clive Bowman; Linda M Thurmond; Allen D Roses
Journal:  Lancet       Date:  2002-03-30       Impact factor: 79.321

6.  Positive and negative associations of HLA class I alleles with allopurinol-induced SCARs in Koreans.

Authors:  Hye-Ryun Kang; Young Koo Jee; Yon-Soo Kim; Chang Hwa Lee; Jae-Woo Jung; Sae Hoon Kim; Heung-Woo Park; Yoon-Seok Chang; In-Jin Jang; Sang-Heon Cho; Kyung-Up Min; Sang-Heon Kim; Kyung Wha Lee
Journal:  Pharmacogenet Genomics       Date:  2011-05       Impact factor: 2.089

7.  Influence of CYP2C9 genetic polymorphism and undernourishment on plasma-free phenytoin concentrations in epileptic patients.

Authors:  Kesavan Ramasamy; Sunil K Narayan; Deepak Gopal Shewade; Adithan Chandrasekaran
Journal:  Ther Drug Monit       Date:  2010-12       Impact factor: 3.681

Review 8.  Pharmacogenetics of allopurinol--making an old drug safer.

Authors:  May P S Lam; Chi K Yeung; Bernard M Y Cheung
Journal:  J Clin Pharmacol       Date:  2013-02-04       Impact factor: 3.126

9.  HLA-B*58:01 allele is associated with augmented risk for both mild and severe cutaneous adverse reactions induced by allopurinol in Han Chinese.

Authors:  Zhi-hao Cao; Zhi-yun Wei; Qin-yuan Zhu; Jun-yu Zhang; Lun Yang; Sheng-ying Qin; Li-yan Shao; Yi-ting Zhang; Jie-kun Xuan; Qiao-li Li; Jin-Hua Xu; Feng Xu; Li Ma; Hui-yuan Huang; Qing-he Xing; Xiao-qun Luo
Journal:  Pharmacogenomics       Date:  2012-07       Impact factor: 2.533

10.  The IMGT/HLA database.

Authors:  James Robinson; Kavita Mistry; Hamish McWilliam; Rodrigo Lopez; Peter Parham; Steven G E Marsh
Journal:  Nucleic Acids Res       Date:  2010-11-11       Impact factor: 16.971
View more
  3 in total

Review 1.  Genetic Basis of Delayed Hypersensitivity Reactions to Drugs in Jewish and Arab Populations.

Authors:  Mohammed Aboukaoud; Shoshana Israel; Chaim Brautbar; Sara Eyal
Journal:  Pharm Res       Date:  2018-09-17       Impact factor: 4.200

Review 2.  Translational Pharmacogenomics: Discovery, Evidence Synthesis and Delivery of Race-Conscious Medicine.

Authors:  Brittney H Davis; Nita A Limdi
Journal:  Clin Pharmacol Ther       Date:  2021-07-29       Impact factor: 6.903

3.  HLA-B*57 Allele Is Associated with Concomitant Anti-tuberculosis and Antiretroviral Drugs Induced Liver Toxicity in Ethiopians.

Authors:  Zelalem Petros; Junko Kishikawa; Eyasu Makonnen; Getnet Yimer; Abiy Habtewold; Eleni Aklillu
Journal:  Front Pharmacol       Date:  2017-02-27       Impact factor: 5.810
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.